Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Changi General Hospital
Age
21–70
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women aged 21-70, with invasive breast cancer, ductal carcinoma in situ (DCIS), Breast Cancer (BRCA) gene or other breast cancer genetic mutation carriers or high risk female patients who are otherwise candidates for conventional NSM/SSM will be eligible for the study. All suitable patients will be offered the option of R-NSM/ R-SSM.
For patients with breast cancer (invasive or DCIS), selection criteria include but not limited to:
1. Early breast cancer
2. Tumor size less than 5 cm
3. No evidence of lymph node metastases
4. No evidence of skin or chest wall invasion.
You may not be if
1. Extensive axillary lymph node metastasis (Stage 3B or later)
2. Heavy smokers (\>20 cigarettes a day)
3. High risk patient with severe and poorly controlled co-morbid conditions (include but not limited to diabetes, heart disease, renal failure or liver dysfunction)
4. Poor performance status or high risk for anaesthesia (ASA 3 and above)
5. Inflammatory or Locally Advanced Breast Cancer (with or without chest wall or skin invasion)
Clareo Health | Surgical and Patient Reported Outcomes in Robotic Mastectomy
